Sophie enjoys developing strong, collaborative relationships with her clients to ensure their needs are met with tailored, practical solutions.
She has extensive experience working in the field of small molecule pharmaceuticals, covering all aspects of pharmaceutical drug development, from new therapeutic compounds and combinations to polymorphs, novel formulations, and clinically effective dosage regimens. Sophie has recently been trusted to defend a patent relating to a pharmaceutical combination currently in a phase 3 clinical trial.
In addition to her work in pharmaceuticals, Sophie provides strategic advice to a number of large, multi-national clients in the high-performance and specialty chemistry sector, dealing with matters relating to engineered polymers, refrigerants, and environmentally friendly industrial materials. Her work includes helping to guide them through patent prosecution and working closely with them in post-grant oppositions and appeals at the EPO.
Sophie also has significant experience handling contentious matters in the consumer products sector, working closely with her client to understand the patent landscape they operate in and to develop an effective strategy for opposing their competitors' patents.
Sophie joined Kilburn & Strode as an associate in 2021 and was promoted to counsel in 2024, in recognition of her expertise and the quality of service she provides to her clients.